The Pineal Gland: Science vs Myth
Descartes called it the seat of the soul. Strassman called it the DMT factory. Borjigin's lab found DMT-producing enzymes throughout the cortex — not just in the pineal. The neuroscience of the most mythologised organ in your skull.
5-MeO-DMT vs Psilocybin: Two Doors to the Same Room
Six hours vs fifteen minutes. Davis (2018) showed 5-MeO-DMT mystical intensity equals high-dose psilocybin. GH001 hit -15.5 MADRS in Phase 2b TRD. The pharmacology, phenomenology, and clinical data on two molecules that occasion mystical experiences of equivalent intensity.
Psilocybin and Nicotine Addiction: How a Single Session Breaks the Hardest Habit
80% quit rate after 2-3 sessions vs 13% for nicotine patches. Johns Hopkins researchers have cracked the neuroscience of tobacco addiction — and it starts with the default mode network.
Psilocybin and Anxiety: The Neuroscience of Dissolving Fear
80% of participants reported sustained anxiety relief after a single psilocybin session. The amygdala quiets, the default mode network resets, and fear patterns built over decades dissolve.
Psilocybin and Cluster Headaches: The Neuroscience of the World's Most Painful Condition
They call them suicide headaches — 10 attacks per day, each rated 10/10 pain. No pharmaceutical reliably stops them. Psilocybin does — even at sub-hallucinogenic doses.
Psilocybin and the Immune System: How Psychedelics Rewrite the Body's Inflammatory Code
Chronic inflammation drives depression, anxiety, neurodegeneration. Psilocybin targets the upstream immune switches directly — through receptors shared with T cells, macrophages, and microglia throughout the body.
Psilocybin and Sleep Architecture: The Neuroscience of Deep Sleep Restoration
Insomnia, fractured REM, and suppressed slow-wave sleep all share a common upstream driver — and psilocybin targets it directly. The emerging neuroscience of psychedelic sleep restoration.
Psilocybin and Chronic Pain: The Neuroscience of Breaking the Pain Cycle
Chronic pain rewires the brain's default mode network in the same way addiction does. Psilocybin may be the first compound that directly targets that architecture.
Psilocybin and Nicotine Addiction: The Neuroscience of Breaking Tobacco Dependence
80% abstinence at 6 months. Johns Hopkins' Matthew Johnson landmark trial rewrites what's possible for smoking cessation. Here is the full neuroscience.
Microdosing Psilocybin: What the Science Actually Says
Does microdosing psilocybin actually work? The most rigorous science — from TrkB-BDNF neuroplasticity to the Szigeti placebo trial — examined with full honesty.
Psilocybin and Neuroplasticity: How a Single Dose Rewires the Brain
A single psilocybin session triggers a 10% increase in dendritic spine density within 24 hours. The structural brain changes persist for weeks. Here is the neuroscience.
Psilocybin and Eating Disorders: The Neuroscience of Breaking Rigid Patterns
Anorexia has the highest mortality of any psychiatric disorder. New clinical trials show psilocybin disrupts the rigid neural patterns that drive eating disorders.
Psilocybin-Assisted Grief Therapy: Clinical Evidence for Healing Complicated Loss
80% of patients showed lasting reductions in grief and death anxiety. The clinical trial evidence for psilocybin-assisted therapy in prolonged grief disorder.
Psilocybin and Grief: The Neuroscience of Healing What Cannot Be Fixed
DMN hyperactivity, prolonged grief disorder, and four mechanisms by which psilocybin may help the brain complete what cannot be fixed.
Cognitive Flexibility and Executive Function Under Psilocybin
How psilocybin rebuilds the prefrontal cortex at the hardware level — REBUS, BDNF, and the 72-hour neuroplasticity window.
Ketamine vs Psilocybin: Two Molecules, Two Paths Out of Depression
Ketamine works in hours. Psilocybin works for months. A complete clinical comparison of the two most promising depression treatments in modern psychiatry.
Micro to Macro: The Science of Psilocybin Dosing Protocols
From 0.1g microdoses to 5g hero doses — five distinct tiers, their pharmacokinetics, and the clinical evidence behind the 25mg therapeutic standard. Griffiths 2016, COMPASS 2022, and the Fadiman vs Stamets debate.
Psilocybin and Alcohol Use Disorder: What the NEJM Trial Found
Bogenschutz 2022 in the New England Journal of Medicine: 83% reduction in heavy drinking days. Two psilocybin sessions restructured craving circuitry where 12 months of pharmacotherapy failed.
Why the Peak Experience Predicts Healing: The Science of the Mystical State
Griffiths' 2006 landmark trial showed that the degree of mystical experience directly predicted therapeutic outcome. The MEQ30 measures it. Here is the neuroscience behind why dissolution heals.
MDMA: The Molecule That Dissolves the Wall Between Self and Other
How MDMA floods the brain with serotonin, triggers a 2× oxytocin surge, silences the amygdala, and reopens a critical window for healing PTSD. The neuroscience behind 67% remission rates in phase 3 trials.
Psilocybin and OCD: Interrupting the Loop
OCD is a circuit problem, not a thought problem. The CSTC loop generates an error signal it cannot terminate. Three clinical trials now show psilocybin interrupts this loop via 5-HT2A activation — with a 73.3% responder rate and 40% full remission.
The Death-Anxiety Trials: Psilocybin and End-of-Life Existential Distress
Two landmark trials in 2016 found that a single psilocybin session produced clinically significant reductions in death anxiety in ~80% of terminal cancer patients. The effects lasted 4.5 years.
Psilocybin and PTSD: The Emerging Evidence
PTSD is not a memory problem — it is a fear extinction failure. New clinical trials are testing whether psilocybin can restore the neuroplasticity that the disorder destroys. The complete emerging science.
Anandamide: The Endocannabinoid That Cacao Unlocks
Your brain produces its own cannabinoid. Ceremonial cacao contains three FAAH-inhibiting compounds that block the enzyme that destroys it — extending the biology of bliss through a mechanism published in Nature in 1996.
Psilocybin and Creativity: What the Data Actually Shows
Controlled trials show psilocybin increases Openness to Experience by more than one standard deviation, persisting for 14 months. The complete neuroscience of creative cognition under psilocybin.
The Integration Window: How to Use the 72-Hour Neuroplasticity Period
BDNF is elevated for 72 hours after psilocybin. New synaptic connections form at measurable rates. What you do in this window determines whether the neuroplasticity produces lasting change — or fades.
MAO Inhibition in Cacao: The Amplification Mechanism
How ceremonial cacao’s β-carboline alkaloids reversibly inhibit monoamine oxidase — extending the life of serotonin, dopamine, and phenylethylamine.
The Inflamed Brain: How Psilocybin Resets the Immune-Neural Interface
Neuroinflammation silently drives depression, cognitive fog, and treatment resistance. How psilocybin modulates microglia, cytokines, and the IDO1 pathway to restore mental clarity.
The Vagus Nerve: Your Body’s Master Reset Button
How the vagus nerve regulates everything from mood to immune function — and why vagal tone is the hidden determinant of psychedelic healing depth.
Oxytocin, Psilocybin, and the Neuroscience of Social Connection
How psilocybin activates oxytocin pathways and dissolves the barriers to human connection — the receptor pharmacology of love, trust, and belonging.
Psilocybin and Depression: What Phase 3 Clinical Trials Actually Show
29% remission at 3 weeks vs 9% placebo. The COMPASS, Imperial College, and Johns Hopkins data — the most rigorous psychedelic trials ever conducted.
Ego Dissolution: The Neuroscience of Losing Yourself to Find Yourself
At high doses, psilocybin dismantles the neural architecture that constructs the experience of being a separate self. Imperial College London has mapped the mechanism.
Theobromine: The Heart-Opening Molecule
The primary alkaloid in ceremonial cacao isn't caffeine. Theobromine — a methylxanthine with a 6–10 hour half-life — dilates blood vessels, crosses the blood-brain barrier, and generates the warm, expansive state that defines the ceremonial cacao experience.
From Spore to Synapse: The Journey of Psilocybin Through Your Body
Psilocybin is pharmacologically inert. The active molecule is psilocin — and the 90-minute biochemical journey between ingestion and peak experience is one of the most precisely mapped stories in psychopharmacology.
The 5-HT2A Blueprint: How Psilocybin Speaks to Your Brain
The single receptor that explains psilocybin's profound transformation of consciousness — block it with one drug and the entire psychedelic experience disappears. The molecular blueprint decoded.
The Set and Setting Science: How Expectation and Environment Shape the Psilocybin Brain
Expectation, environment, and intention are not soft variables. They are pharmacologically active — shaping receptor binding, network dynamics, and long-term therapeutic outcomes in ways that clinical data now confirms.
Psilocybin and Addiction: Rewiring the Compulsive Brain
How 80% tobacco abstinence rates and 84% reductions in alcohol use are redefining what addiction treatment can achieve — and the precise neuroscience of why it works.
The Entropic Brain Hypothesis
How increased neural entropy during psychedelic states allows the brain to escape fixed attractor states and build new cognitive architectures.
Microdosing with Ceremonial Cacao: The Daily Integration Protocol
Sub-perceptual benefits of daily integration: improving divergent thinking and serotonergic baseline using ceremonial cacao as a psychedelic stack.
Psilocybin-Assisted Therapy for Combat Veterans
Three neurobiological mechanisms through which psilocybin addresses the structural brain changes caused by combat trauma — with clinical data from active veteran trials.
The Cacao-Psilocybin Synergy Protocol
Four neurochemical mechanisms through which ceremonial-grade cacao primes the nervous system and amplifies psilocybin's therapeutic effects.
BDNF and the Architecture of Neuroplasticity
How psilocybin triggers the release of brain-derived neurotrophic factor and physically rebuilds neural architecture at the synaptic level.
The Default Mode Network: Your Brain's Autopilot
Mapping the neural architecture that locks consciousness into repetitive thought patterns — and how psilocybin dissolves those fixed attractor states.
Your Brain on Psilocybin: The Complete Neuroscience of Neural Reconstruction
How psilocybin fundamentally rewrites the brain's operating system — the complete neuroscience of mystical experience, neuroplasticity, and lasting therapeutic change.